Autoimmune pulmonary alveolar proteinosis developed during treatment for systemic sclerosis: a case report

Autoimmune pulmonary alveolar proteinosis developed during treatment for systemic sclerosis: a case report

Abstract Background Reports of autoimmune diseases coexisting with autoimmune pulmonary alveolar proteinosis (autoimmune PAP; APAP) are extremely rare. APAP coexisting with autoimmune diseases may often be misdiagnosed as connective tissue disease–associated interstitial lung disease (ILD). Here, we...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomoki Kozono, Kentaro Tanaka, Tomoko Yagi, Kazuto Kamikawaji, Masaki Watanabe, Azusa Iwanaga, Minako Hamada, Yoshifusa Koreeda, Hiromasa Inoue, Ikkou Higashimoto
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Pulmonary Medicine
Subjects:
Autoimmune pulmonary alveolar proteinosis
Autoimmune diseases
Sargramostim inhalation
Anti-GM-CSF antibodies
Online Access:https://doi.org/10.1186/s12890-025-03489-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12890-025-03489-0

Similar Items